StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.09−0.03 (-0.96%)

Close on Nov 13, 2026Market cap $769.99MP/E –Yield –

Ardelyx cash

Cash and short-term investments held at the end of each period.

Ardelyx's cash was $281.83M at Jun 30, 2026. For fiscal 2025 it was $264.69M, up 5.8% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $264.69M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$264.69M+5.8%
FY2024Dec 31, 2024$250.10M+35.7%
FY2023Dec 31, 2023$184.30M+48.7%
FY2022Dec 31, 2022$123.91M+6.2%
FY2021Dec 31, 2021$116.69M-37.4%
FY2020Dec 31, 2020$186.48M-24.7%
FY2019Dec 31, 2019$247.49M+47.2%
FY2018Dec 31, 2018$168.13M+25.4%
FY2017Dec 31, 2017$134.02M-33.3%
FY2016Dec 31, 2016$200.89M+87.7%
FY2015Dec 31, 2015$107.00M-0.3%
FY2014Dec 31, 2014$107.29M+211.6%
FY2013Dec 31, 2013$34.44M+4.7%
FY2012Dec 31, 2012$32.90M+205.2%
FY2011Dec 31, 2011$10.78M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$281.83M+18.2%
Q1 FY2026Mar 31, 2026$238.07M+11.3%
Q4 FY2025Dec 31, 2025$264.69M+5.8%
Q3 FY2025Sep 30, 2025$242.71M+27.5%
Q2 FY2025Jun 30, 2025$238.45M+28.2%
Q1 FY2025Mar 31, 2025$213.95M+5.6%
Q4 FY2024Dec 31, 2024$250.10M+35.7%
Q3 FY2024Sep 30, 2024$190.40M+15.3%
Q2 FY2024Jun 30, 2024$185.96M+45.8%
Q1 FY2024Mar 31, 2024$202.58M+55.4%
Q4 FY2023Dec 31, 2023$184.30M+48.7%
Q3 FY2023Sep 30, 2023$165.08M+82.2%
Q2 FY2023Jun 30, 2023$127.58M+57.5%
Q1 FY2023Mar 31, 2023$130.37M+45.3%
Q4 FY2022Dec 31, 2022$123.91M+6.2%
Q3 FY2022Sep 30, 2022$90.62M-36.0%
Q2 FY2022Jun 30, 2022$81.01M-52.8%
Q1 FY2022Mar 31, 2022$89.70M-49.7%
Q4 FY2021Dec 31, 2021$116.69M-37.4%
Q3 FY2021Sep 30, 2021$141.70M-23.6%
Q2 FY2021Jun 30, 2021$171.80M-16.0%
Q1 FY2021Mar 31, 2021$178.22M-20.2%
Q4 FY2020Dec 31, 2020$186.48M-24.7%
Q3 FY2020Sep 30, 2020$185.41M+79.1%
Q2 FY2020Jun 30, 2020$204.52M+65.0%
Q1 FY2020Mar 31, 2020$223.25M+47.3%
Q4 FY2019Dec 31, 2019$247.49M+47.2%
Q3 FY2019Sep 30, 2019$103.54M-44.5%
Q2 FY2019Jun 30, 2019$123.93M-41.8%
Q1 FY2019Mar 31, 2019$151.55M+18.8%
Q4 FY2018Dec 31, 2018$168.13M+25.4%
Q3 FY2018Sep 30, 2018$186.42M+44.2%
Q2 FY2018Jun 30, 2018$212.77M+43.0%
Q1 FY2018Mar 31, 2018$127.54M-26.5%
Q4 FY2017Dec 31, 2017$134.02M-33.3%
Q3 FY2017Sep 30, 2017$129.30M-43.8%
Q2 FY2017Jun 30, 2017$148.76M–
Q1 FY2017Mar 31, 2017$173.47M–
Q4 FY2016Dec 31, 2016$200.89M–
Q3 FY2016Sep 30, 2016$230.11M–

More Ardelyx figures

See a number that looks wrong?